CD4+CD25HIGHFOXP3+T-REGULATORY CELLS IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB

被引：0
|
作者：
Di Sabatino, A. [1 ]
Rosado, M. [2 ]
Biancheri, P. [1 ]
Cazzola, P. [1 ]
Rovedatti, L. [1 ]
Vanoli, A. [1 ]
Cantoro, L. [1 ]
Carsetti, R. [2 ]
Corazza, G. R. [1 ]
机构：
[1] Univ Pavia, Fdn IRCCS Policlin S Matteo, Ctr Studio & Cura Malattie Infiammatorie Cron Int, Dept Med 1, Pavia, Italy
[2] IRCCS Osped Pediat Bambino Gesu, Res Ctr, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2008年 / 40卷
关键词：
D O I：
10.1016/S1590-8658(08)60111-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC3.03.6
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [21] FoxP3+CD4+CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease
    Kelsen, J
    Agnholt, J
    Hoffmann, HJ
    Romer, JL
    Hvas, CL
    Dahlerup, JF
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 141 (03): : 549 - 557
  • [22] sCTLA-4, CD4+CD25+Foxp3+ regulatory T cells in Behcet's disease patients
    Demir, N.
    Ilhan, F.
    Demir, T.
    Godekmerdan, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : S116 - S117
  • [23] In vitro-expanded CD4+CD25highFoxp3+ regulatory T cells controls corneal allograft rejection
    Guo, Xuming
    Jie, Ying
    Ren, Dong
    Zeng, Hui
    Zhang, Yingnan
    He, Yan
    Pan, Zhiqiang
    HUMAN IMMUNOLOGY, 2012, 73 (11) : 1061 - 1067
  • [24] Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease
    Saruta, Masayuki
    Yu, Qj T.
    Fleshner, Phillip R.
    Mantel, Pierre-Yves
    Schmidt-Weber, Carsten B.
    Banham, Alison H.
    Papadakis, Konstantinos A.
    CLINICAL IMMUNOLOGY, 2007, 125 (03) : 281 - 290
  • [25] The Significance of Monitoring Peripheral CD4+T-Cells Expressing Regulatory CD25High+and the Immune-Deficiency CD4+T-Cells Lacking CD28 in Patients with Crohn's Disease Under Infliximab Therapy
    Kamikozuru, Koji
    Fukunaga, Ken
    Miwa, Hiroto
    Matsumoto, Takayuki
    GASTROENTEROLOGY, 2009, 136 (05) : A255 - A255
  • [26] Factors regulating apoptosis and homeostasis of CD4+CD25highFOXP3+ regulatory T cells are new therapeutic targets
    Yang, Xiao-Feng
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1472 - 1499
  • [27] CD4+CD25highFOXP3+ regulatory T cells in peripheral blood are primarily of effector memory phenotype -: Reply
    Cesana, Giovanni
    Kaufman, Howard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2630 - 2632
  • [28] CD25+ CD4+ regulatory T cells in patients with Kawasaki disease
    Furuno, K
    Yuge, T
    Kusuhara, K
    Takada, H
    Nishio, H
    Khajoee, V
    Ohno, T
    Hara, T
    JOURNAL OF PEDIATRICS, 2004, 145 (03): : 385 - 390
  • [29] Selective expansion of human regulatory (CD4+CD25+CD127lowFOXP3+) cells to high purity by inhibiting expansion of CD4+CD25+CD127highFOXP3- conventional T cells with rapamycin
    Hou, J. Z.
    Zanibricki, V.
    Zeiser, R.
    Negrin, R. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 109 - 109
  • [30] CD4+CD25+ regulatory T cells in health and disease
    Liu, HY
    Leung, BP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (5-6): : 519 - 524
12345